{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T03:41:36Z","timestamp":1778902896080,"version":"3.51.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,10,18]],"date-time":"2018-10-18T00:00:00Z","timestamp":1539820800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1038\/s41390-018-0206-6","type":"journal-article","created":{"date-parts":[[2018,10,18]],"date-time":"2018-10-18T11:20:43Z","timestamp":1539861643000},"page":"837-841","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Ten years of screening for congenital disorders of glycosylation in Argentina: case studies and pitfalls"],"prefix":"10.1038","volume":"84","author":[{"given":"Carla Gabriela","family":"Asteggiano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magali","family":"Papazoglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Beatriz","family":"Bistu\u00e9 Mill\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Fernanda","family":"Peralta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nydia Beatriz","family":"Azar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norma Sp\u00e9cola","family":"Sp\u00e9cola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norberto","family":"Guelbert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niels Suldrup","family":"Suldrup","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcela","family":"Pereyra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raquel","family":"Dodelson de Kremer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,10,18]]},"reference":[{"key":"206_CR1","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s10545-017-0050-6","volume":"40","author":"J Jaeken","year":"2017","unstructured":"Jaeken, J., & P\u00e9anne, R. What is new in CDG? J. Inherit. Metab. Dis. 40, 569\u2013586 (2017).","journal-title":"J. Inherit. Metab. Dis."},{"key":"206_CR2","doi-asserted-by":"publisher","unstructured":"P\u00e9anne R. et al. Congenital disorders of glycosylation (CDG): Quo vadis? Eur J Med Genet [Internet] 2017; https:\/\/doi.org\/10.1016\/j.ejmg.2017.10.012 .","DOI":"10.1016\/j.ejmg.2017.10.012"},{"key":"206_CR3","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s10719-015-9639-x","volume":"33","author":"MV Scherpenzeel","year":"2016","unstructured":"ScherpenzeelM. V., WillemsE. & LefeberD. J. Clinical diagnostics and therapy monitoring in the congenital disorders of glycosylation. Glycoconj J. 33, 345\u2013358 (2016).","journal-title":"Glycoconj J."},{"key":"206_CR4","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1146\/annurev-neuro-071714-034019","volume":"38","author":"HH Freeze","year":"2015","unstructured":"FreezeH. H., EklundE. A. NgB. G. & PattersonM. C. Neurological aspects of human glycosylation disorders. Annu Rev Neurosci. 38, 105\u2013125 (2015).","journal-title":"Annu Rev Neurosci."},{"key":"206_CR5","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.clinbiochem.2008.12.013","volume":"42","author":"E Quintana","year":"2009","unstructured":"Quintana, E. et al. Screening for congenital disorders of glycosylation (CDG): transferrin HPLC versus isoelectric focusing (IEF). Clin. Biochem 42, 408\u2013415 (2009).","journal-title":"Clin. Biochem"},{"key":"206_CR6","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1136\/adc.65.1.107","volume":"65","author":"H Stibler","year":"1990","unstructured":"Stibler, H. & Jaeken, J. Carbohydrate deficient serum transferrin in a new systemic hereditary syndrome. Arch. Dis. Child 65, 107\u2013111 (1990).","journal-title":"Arch. Dis. Child"},{"key":"206_CR7","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1002\/1098-1004(200011)16:5<386::AID-HUMU2>3.0.CO;2-Y","volume":"16","author":"G Matthijs","year":"2000","unstructured":"Matthijs, G. et al. Mutations in PMM2 that cause congenital disorders of glycosylation, type Ia (CDG-Ia). Hum. Mutat. 16, 386\u2013394 (2000).","journal-title":"Hum. Mutat."},{"key":"206_CR8","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1007\/s10545-011-9370-0","volume":"34","author":"DJ Lefeber","year":"2011","unstructured":"LefeberD. J., MoravaE. & JaekenJ. How to find and diagnose a CDG due to defective N-glycosylation. J. Inherit. Metab. Dis. 34, 849\u2013852 (2011).","journal-title":"J. Inherit. Metab. Dis."},{"key":"206_CR9","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.clinbiochem.2014.09.022","volume":"48","author":"A Z\u00fchlsdorf","year":"2015","unstructured":"Z\u00fchlsdorf, A. et al. Transferrin variants\u202f: pitfalls in the diagnostics of congenital disorders of glycosylation. Clin. Biochem 48, 11\u201313 (2015).","journal-title":"Clin. Biochem"},{"key":"206_CR10","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.cca.2014.05.011","volume":"436","author":"JH Park","year":"2014","unstructured":"Park, J. H. et al. The novel transferrin E592A variant impairs the diagnostics of congenital disorders of glycosylation. Clin. Chim. Acta 436, 135\u2013139 (2014).","journal-title":"Clin. Chim. Acta"},{"key":"206_CR11","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s10719-012-9445-7","volume":"30","author":"G Matthijs","year":"2013","unstructured":"Matthijs, G. et al. Approaches to homozygosity mapping and exome sequencing for the identification of novel types of CDG. Glycoconj J. 30, 67\u201376 (2013).","journal-title":"Glycoconj J."},{"key":"206_CR12","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/8904_2011_18","volume":"1","author":"MB Bistue","year":"2011","unstructured":"Bistue, M. B. et al. Two Argentinean siblings with CDG-Ix : a novel type of congenital disorder of glycosylation?. JIMD Rep 1, 65\u201372 (2011).","journal-title":"JIMD Rep"},{"key":"206_CR13","doi-asserted-by":"publisher","first-page":"e1003989","DOI":"10.1371\/journal.pgen.1003989","volume":"9","author":"D Rymen","year":"2013","unstructured":"Rymen, D. et al. MAN1B1 deficiency : an unexpected CDG-II. PLoS Genet. 9, e1003989 (2013).","journal-title":"PLoS Genet."},{"key":"206_CR14","first-page":"e109","volume":"113","author":"F Cammarata-scalisi F","year":"2015","unstructured":"Cammarata-scalisi F, F. et al. Alelo doble mutante en el gen EXT1 no informado previamente en una adolescente con exostosis m\u00faltiple hereditaria. Archivos argentinos de pediatr\u00eda 113, e109\u2013e112 (2015).","journal-title":"Archivos argentinos de pediatr\u00eda"},{"key":"206_CR15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep06407","volume":"4","author":"MA Delgado","year":"2014","unstructured":"Delgado, M. A. et al. A broad spectrum of genomic changes in latinamerican patients with EXT1\/EXT2-CDG. Sci. Rep. 4, 1\u20137 (2014).","journal-title":"Sci. Rep."},{"key":"206_CR16","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1002\/humu.21123","volume":"30","author":"I Jennes","year":"2009","unstructured":"Jennes, I. et al. Multiple osteochondromas: mutation update and description of the multiple osteochondromas mutation database (MOdb). Hum. Mutat. 30, 1620\u20131627 (2009).","journal-title":"Hum. Mutat."},{"key":"206_CR17","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1373\/clinchem.2003.023341","volume":"49","author":"A Helander","year":"2003","unstructured":"Helander, A., Husa, A. & Jeppsson, J. O. Improved HPLC method for carbohydrate-deficient transferrin in serum. Clin. Chem. 49, 1881\u20131890 (2003).","journal-title":"Clin. Chem."},{"key":"206_CR18","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/ng0597-88","volume":"16","author":"G Matthijs","year":"1997","unstructured":"Matthijs, G. et al. Mutations in PMM2, a phosphomannomutase gene on chromosome 16p13, in carbohydrate-deficient glycoprotein type 1 syndrome (Jaeken syndrome). Nat. Genet 16, 88\u201392 (1997).","journal-title":"Nat. Genet"},{"key":"206_CR19","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1136\/jmg.37.8.579","volume":"37","author":"S Vuillaumier-barrot","year":"2000","unstructured":"Vuillaumier-barrot, S. et al. Identification of four novel PMM2 mutations in congenital disorders of glycosylation (CDG) Ia French patients.J. Med. Genet. 37, 579\u2013580 (2000).","journal-title":"J. Med. Genet."},{"key":"206_CR20","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/S0888-7543(05)80244-7","volume":"14","author":"ND Leslie","year":"1992","unstructured":"Leslie, N. D. et al. The human galactose-1-phosphate uridyltransferase gene. Genomics 14, 474\u2013480 (1992).","journal-title":"Genomics"},{"key":"206_CR21","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/0888-7543(92)90453-Y","volume":"12","author":"JK Reichardt","year":"1992","unstructured":"ReichardtJ. K., . BelmontJ. W. LevyH. L. WooS. L. Characterization of two missense mutations in human galactose-1-phosphate uridyltransferase: different molecular mechanisms for galactosemia.Genomics 12, 596\u2013600 (1992).","journal-title":"Genomics"},{"key":"206_CR22","doi-asserted-by":"publisher","first-page":"10005","DOI":"10.1074\/jbc.M109.093666","volume":"285","author":"RZ Zhang","year":"2010","unstructured":"Zhang, R. Z. et al. Recessive COL6A2 C-globular missense mutations in Ullrich congenital muscular dystrophy: role of the C2a splice variant. J. Biol. Chem. 285, 10005\u201310015 (2010).","journal-title":"J. Biol. Chem."},{"key":"206_CR23","doi-asserted-by":"crossref","unstructured":"Baharian Soheil et al. The Great Migration and African-American Genomic Diversity. PLoS Genet 12:e1006059 (2016).","DOI":"10.1371\/journal.pgen.1006059"},{"key":"206_CR24","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.bbadis.2009.01.003","volume":"1792","author":"S Gr\u00fcnewald","year":"2009","unstructured":"Gr\u00fcnewald, S. The clinical spectrum of phosphomannomutase 2 de fi ciency (CDG-Ia). Biochim. Biophys. Acta. 1792, 827\u2013834 (2009).","journal-title":"Biochim. Biophys. Acta."},{"key":"206_CR25","doi-asserted-by":"publisher","first-page":"22498","DOI":"10.1074\/jbc.M302850200","volume":"278","author":"C Thiel","year":"2003","unstructured":"Thiel, C. et al. A new type of congenital disorders of glycosylation (CDG-Ii) provides new insights into the early steps of dolichol-linked oligosaccharide biosynthesis. J. Biol. Chem. 278, 22498\u201322505 (2003).","journal-title":"J. Biol. Chem."},{"key":"206_CR26","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.nmd.2013.12.010","volume":"24","author":"DM Monies","year":"2014","unstructured":"Monies, D. M., Al-hindi, H. N. & Al-muhaizea, M. A. ScienceDirect Clinical and pathological heterogeneity of a congenital disorder of glycosylation manifesting as a myasthenic\/myopathic syndrome. Neuromuscul. Disord. [Internet] 24, 353\u2013359 (2014).","journal-title":"Neuromuscul. Disord. [Internet]"},{"key":"206_CR27","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1093\/brain\/awt010","volume":"136","author":"J Cossins","year":"2013","unstructured":"Cossins, J. et al. Congenital myasthenic syndromes due to mutations in ALG2 and ALG14. Brain 136, 944\u2013956 (2013).","journal-title":"Brain"},{"key":"206_CR28","doi-asserted-by":"publisher","first-page":"S21","DOI":"10.3233\/JND-150098","volume":"2","author":"T Evangelista","year":"2015","unstructured":"EvangelistaT., HannaM. & LochmH. Congenital myasthenic syndromes with predominant limb girdle weakness. J. Neuromuscul. Dis. 2, S21\u2013S29 (2015).","journal-title":"J. Neuromuscul. Dis."},{"key":"206_CR29","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.tibs.2015.03.002","volume":"40","author":"T Hennet","year":"2015","unstructured":"HennetT., & CabalzarJ. Congenital disorders of glycosylation : a concise chart of glycocalyx dysfunction. Trends Biochem. Sci. 40, 377\u2013384 (2015).","journal-title":"Trends Biochem. Sci."},{"key":"206_CR30","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1021\/pr4008305","volume":"13","author":"KP Coss","year":"2014","unstructured":"Coss, K. P. et al. N-glycan abnormalities in children with galactosemia. J. Proteome Res 13, 385\u2013394 (2014).","journal-title":"J. Proteome Res"}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41390-018-0206-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41390-018-0206-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41390-018-0206-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:24:21Z","timestamp":1684617861000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-018-0206-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,18]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["206"],"URL":"https:\/\/doi.org\/10.1038\/s41390-018-0206-6","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,18]]},"assertion":[{"value":"14 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Procedures employed were reviewed and approved by the appropriate institutional review committees. Written informed consent was obtained from the patients and their parents to participate in this study, and they allowed us to submit this manuscript with images for publication. Copies of the written consents are available for review. The study was approved by the Ethics Committee of the Children\u2019s Hospital of C\u00f3rdoba (CIEIS) Act N\u00ba 95\/2005\/2007\/2016. All studies were carried out in accordance with the World Medical Association Declaration of Helsinki.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}